Form 4: Shanghai Fosun Pharmaceutical Sells Natures Sunshine Products Shares
SEC Filing
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reports a transaction involving the sale of Natures Sunshine Products Inc. shares on October 15, 2024.
Summary
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a 10% owner of Natures Sunshine Products Inc., filed a Form 4 indicating changes in beneficial ownership.
- On October 15, 2024, the company sold 2,300 shares of common stock at a price of $13.02 per share.
- Following the transaction, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. directly owns 2,854,607 shares and indirectly owns 64,167 shares through its wholly-owned subsidiary, Fosun Industrial Co., Limited.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of a share sale. The impact depends on the size of the sale relative to the total holdings and market perception.
Industry Context
Form 4 filings are standard disclosures required by the SEC when significant changes in ownership occur for company insiders and large shareholders. This sale could be for portfolio rebalancing or other strategic reasons.
Stakeholder Impact
- The sale of shares could potentially impact shareholder confidence, depending on the market's interpretation of the transaction.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date of transaction: Sale of common stock |
| 10/17/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.